Top Markets
#1 Derive Derive +33.59%
#2 Cross Cross +17.56%
#3 The Bitcoin Bull The Bitcoin Bull +14.37%
#4 Audiera Audiera +9.42%
#5 Gama Token Gama Token +9.19%
#6 Geodnet Geodnet +9.10%
#7 Velvet Velvet +8.40%
#8 Biconomy Biconomy +7.55%
#9 Starpower Starpower +7.38%
#10 Based Based +7.36%
Coin of the day
Derive Derive
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Gemina Laboratories Ltd. Gemina Laboratories Ltd.

Gemina Laboratories Ltd.

GLAB
Rankning i aktier #35861
Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the... Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the research, development, and commercialization of in-vitro diagnostics. The firm invents innovative surface functionalization chemistries for identifying pathogens and biomarkers. Among its current projects, Gemina is advancing the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip specifically designed to detect active COVID-19 infections. The company maintains its headquarters in Vancouver, Canada.
Aktiekurs
$0.04377166
Senast synkroniserad: 2026-02-05
Marknadsvärde
$3.35M
Förändring (1 dag)
-0.30%
Förändring (1 år)
-87.90%
Land
CA
Handel Gemina Laboratories Ltd. (GLAB)

Kategori

Healthcare
Aktiekurshistorik för Gemina Laboratories Ltd. (GLAB)
Högsta slutkurs: $0.04 den 2026-02-01

Lägsta slutkurs: $0.30 den 2021-08-01
Aktiekurshistorik för Gemina Laboratories Ltd. från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 121.89%
2025 -80.71%
2024 48.10%
2023 1.71%
2022 16.33%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE